As immunotherapy becomes a cornerstone of cancer treatment, some of the top U.S. cancer centers and health systems are accelerating research efforts to identify the biological mechanisms behind ...

Panelists discuss several promising new agents for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), including an LPA1 receptor antagonist showing lung function ...

OpEd: Many of Markey’s clinical trials funded by the NIH give Kentucky patients access to the latest treatments — including ...

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...

Boehringer Ingelheim shares how it is addressing healthcare inequalities in cancer care, with a particular emphasis on ...

Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 pandemic. Prophylactic cancer vaccines have prevented several malignancies by ...

A research team led by Prof. Li Hai from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has ...

Mike Dovidio says adding scanning power can make drug spending more efficient — and save some patients' lives.

The partners have committed to awarding two grants, totaling around $2.3 million, to researchers studying this lung cancer subset.

The results suggest toxicity may not be as pervasive as previously thought, which argues for more-personalized monitoring.